We bridge research to
unmet needs by translating
discoveries to new medicine

Snapshot as of end 2023

19

Pipeline
Projects

5

Innovation
Platforms

12

Public and Private Collaborations

5

Licensing Deals
(since 2018)

The Experimental Drug Development Centre (EDDC) is Singapore’s national platform for drug discovery and development. We collaborate with public sector and industry partners to translate groundbreaking scientific discoveries into valuable biotherapeutic candidates.

About Us

17

Pipeline Projects

5

Innovation Platforms

9

Public and Private Collaborations

5

Licensing Deals
(since 2018)

The Experimental Drug Development Centre (EDDC) is Singapore’s national platform for drug discovery and development, formed from the integration of the Experimental Therapeutics Centre (ETC), Drug, Discovery and Development (D3), and Experimental Biotherapeutics Centre (EBC) in 2019.

Pipeline

EDDC aims to develop innovative therapeutics and companion diagnostics that have the potential to improve and save the lives of patients in Singapore and beyond. We want to advance the development of safe and effective therapies that address unmet medical needs.

 

We welcome partnerships with collaborators who share our vision, to jointly accelerate the development of our pipeline assets.

Newsroom

Recent News

Partner with Us

EDDC is equipped with comprehensive capabilities for advancing the discovery and development of small molecule or antibody-based drugs, as well as companion diagnostics.

As a publicly-funded researcher, you can benefit from our extensive expertise and capabilities to advance your drug discovery project in various ways.

Collaborations

Consultancy

Services